Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Covalent Alkynylpyridopyrimidinones Targeting Cysteine 775 of the Epidermal Growth Factor Receptor Overcome Resistance to Current Therapies

Lookup NU author(s): Dr Hannah StewartORCiD, Dr Claire Jennings, Dr Islam Al-Khawaldeh, Dr Mathew MartinORCiD, Dr Richard NobleORCiD, Nicole Phillips, Sara Pintar, Dr Lisa PrendergastORCiD, Huw ThomasORCiD, Dr Jessica WattORCiD, Dr Anita Wittner, Dr Agnieszka Bronowska, Dr Celine CanoORCiD, Professor Martin NobleORCiD, Professor Steve WedgeORCiD, Professor Mike WaringORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Publication metadata

Author(s): Stewart HL, Bordoni C, Jennings CE, Al-Khawaldeh I, Martin MP, Noble RA, Phillips N, Pintar S, Prendergast L, Thomas HD, Wang L-Z, Watt JE, Wittner A, Bronowska AK, Cano C, Noble MEM, Wedge SR, Waring MJ

Publication type: Article

Publication status: Published

Journal: Journal of Medicinal Chemistry

Year: 2026

Volume: 69

Issue: 1

Pages: 533-552

Online publication date: 23/12/2025

Acceptance date: 12/12/2025

Date deposited: 20/01/2026

ISSN (print): 0022-2623

ISSN (electronic): 1520-4804

Publisher: American Chemical Society

URL: https://doi.org/10.1021/acs.jmedchem.5c02924

DOI: 10.1021/acs.jmedchem.5c02924


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Astex Pharmaceuticals (Newcastle Drug Discovery Alliance)
Cancer Research UK (Drug Discovery programme grants : C2115/A21421, DRCDDRPGMApr2020\100002)
the Medical Research Council (Developmental Pathways Funding Scheme, MR/X004872/1)

Share